Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung- The Knockout Punch

被引:14
作者
Tjong, M. C. [1 ]
Louie, A., V [1 ]
Singh, A. K. [2 ]
Videtic, G. [3 ]
Stephans, K. [3 ]
Plumridge, N. [4 ]
Harden, S. [4 ]
Slotman, B. J. [5 ]
Alongi, F. [6 ,7 ]
Guckenberger, M. [8 ]
Siva, S. [4 ]
机构
[1] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Amsterdam Univ Med Ctr VUMC, Amsterdam, Netherlands
[6] IRCCS Sacro Cuore Don Calabria Hosp, Adv Radiat Oncol Dept, Negrar Verona, Italy
[7] Univ Brescia, Brescia, Italy
[8] Univ Zurich, Univ Hosp Zurich, Zurich, Switzerland
关键词
Ablative; lung; metastasis; NSCLC; radiotherapy; stereotactic; MEDICALLY INOPERABLE PATIENTS; RADIATION-THERAPY; CANCER; OLIGOMETASTASES; OUTCOMES; PHASE-2; TUMORS; SBRT; METASTASES; MANAGEMENT;
D O I
10.1016/j.clon.2022.02.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This overview summarises the current evidence on efficacy and safety of single-fraction stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung metastases, in comparison with the more widely adapted multi-fraction SABR regimens. A literature search using the Medline database through PubMed was carried out using the following key words: ('stereotactic' or 'sabr' or 'sbrt'), ('radiotherapy' or 'radiation therapy'), ('lung' or 'thorax' or 'thoracic' or 'chest'), ('cancer' or 'metasta-' or 'oligometasta-'), alongside: (i) ('single-fraction' or 'single-dose') to identify trials and cohort studies with single-fraction SABR to lung malignant tumours and (ii) ('fraction' or 'schedule') limiting the search to 'clinical trial' and 'randomized controlled trial' to ensure thorough capture of lung SABR trials comparing different fractionations. The review discusses the radiobiological, technical and organ at risk considerations of single-fraction SABR to the lung. (C) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E183 / E194
页数:12
相关论文
共 50 条
[41]   Stereotactic Body Radiotherapy for Lung Tumors at the Pulmonary Hilum [J].
Oshiro, Yoshiko ;
Aruga, Takashi ;
Tsuboi, Koji ;
Marino, Kan ;
Hara, Ryusuke ;
Sanayama, Yasushi ;
Itami, Jun .
STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (05) :274-279
[42]   Lung stereotactic body radiotherapy after past ablative therapy: a single institution case series [J].
Wegner, Rodney E. ;
Ahmed, Nissar ;
Hasan, Shaakir ;
Schumacher, Lana Y. ;
Colonias, Athanasios .
LUNG CANCER MANAGEMENT, 2018, 7 (03)
[43]   Feasibility of a Single-Fraction Stereotactic Dose of 30 Gy to Solitary Lung Lesions on Halcyon [J].
Misa, Joshua ;
Knight, James A. ;
Pokhrel, Damodar .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
[44]   On the use of volumetric-modulated arc therapy for single-fraction thoracic vertebral metastases stereotactic body radiosurgery [J].
Pokhrel, Damodar ;
Sood, Sumit ;
McClinton, Christopher ;
Shen, Xinglei ;
Badkul, Rajeev ;
Jiang, Hongyu ;
Mallory, Matthew ;
Mitchell, Mellissa ;
Wang, Fen ;
Lominska, Christopher .
MEDICAL DOSIMETRY, 2017, 42 (01) :69-75
[45]   Can reducing planning safety margins broaden the inclusion criteria for lung stereotactic ablative body radiotherapy? [J].
Ghandourh, Wsam ;
Batumalai, Vikneswary ;
Boxer, Miriam ;
Holloway, Lois .
JOURNAL OF MEDICAL RADIATION SCIENCES, 2021, 68 (03) :298-309
[46]   Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience [J].
Yu, Nathan Y. ;
Sio, Terence T. ;
Lyons, Mark K. ;
Vora, Sujay A. ;
Turkmani, Ali ;
Brown, Paul D. ;
Park, Sean S. ;
Leenstra, James L. ;
Bendok, Bernard R. ;
Schild, Steven E. ;
Ashman, Jonathan B. .
JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 80 :74-78
[47]   On the dose to a moving target in stereotactic ablative body radiotherapy to lung tumors [J].
Feygelman, V. ;
Dilling, T. J. ;
Moros, E. G. ;
Zhang, G. G. .
MICRO-MINI & NANO-DOSIMETRY & INNOVATIVE TECHNOLOGIES IN RADIATION THERAPY (MMND&ITRO2016), 2017, 777
[48]   NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy [J].
Hardcastle, Nicholas ;
Hofman, Michael S. ;
Lee, Ching-Yu ;
Callahan, Jason ;
Selbie, Lisa ;
Foroudi, Farshad ;
Shaw, Mark ;
Chander, Sarat ;
Lim, Andrew ;
Chesson, Brent ;
Murphy, Declan G. ;
Kron, Tomas ;
Siva, Shankar .
RADIATION ONCOLOGY, 2019, 14 (01)
[49]   Repeated Stereotactic Body Radiotherapy for Lung Malignancies: Toxicity Can Be Reduced by Sparing Lung Irradiation [J].
Watanabe, Shou ;
Yamazaki, Hideya ;
Kimoto, Takyua ;
Suzuki, Gen ;
Yamada, Kei .
ANTICANCER RESEARCH, 2022, 42 (05) :2701-2709
[50]   PREDICTION OF CHEST WALL TOXICITY FROM LUNG STEREOTACTIC BODY RADIOTHERAPY (SBRT) [J].
Stephans, Kevin L. ;
Djemil, Toufik ;
Tendulkar, Rahul D. ;
Robinson, Cliff G. ;
Reddy, Chandana A. ;
Videtic, Gregory M. M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02) :974-980